SNA
56
-2
HOG
26
-3
AKAM
50
-4
TJX
53
-6
GS
55
-3
BF.B
32
-4
FLR
50
-2
FIS
45
-3
INTU
54
-3
DFS
65
-5
IBM
53
-2
NFLX
68
-5
PNW
55
-2
EQR
36
-3
CMG
58
-5
EMC
39
-3
AMAT
44
2
PEG
55
-2
QRVO
16
-4
SPG
48
-2
SNA
56
-2
HOG
26
-3
AKAM
50
-4
TJX
53
-6
GS
55
-3
BF.B
32
-4
FLR
50
-2
FIS
45
-3
INTU
54
-3
DFS
65
-5
IBM
53
-2
NFLX
68
-5
PNW
55
-2
EQR
36
-3
CMG
58
-5
EMC
39
-3
AMAT
44
2
PEG
55
-2
QRVO
16
-4
SPG
48
-2
Financhill
Back

Nuveen Municipal Credit Income Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
26

NZF
Nuveen Municipal Credit Income Fund

Last Price:
$12.11
Seasonality Move:
0.74%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
26
Nuveen Municipal Credit Income Fund (NZF) is a Sell

Is Nuveen Municipal Credit Income Fund a Buy, Sell or Hold?

  • The current Nuveen Municipal Credit Income Fund [NZF] share price is $12.12. The Score for NZF is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NZF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NZF Stock Price Chart

What is Nuveen Municipal Credit Income Fund's stock price today?

  • The Nuveen Municipal Credit Income Fund share price today is $12.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NZF is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $41.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

NZF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 29.62 Sell
Chaikin Money Flow: -1000760 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.37 - 13.01) Sell
Bollinger Bands (100): (12.54 - 12.98) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.69 Buy
Relative Strength Index (14 RSI): 73.75 Buy
Chaikin Money Flow: -154898 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.72 - 37.64) Buy
Bollinger Bands (100): (6.81 - 25.85) Buy

NZF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.27 Sell
20-day SMA: 12.67 Sell
50-day SMA: 12.65 Sell
200-day SMA: 12.45 Sell
8-day EMA: 12.31 Sell
20-day EMA: 12.51 Sell
50-day EMA: 12.64 Sell
200-day EMA: 12.46 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.54 Buy
20-day SMA: 33.12 Buy
50-day SMA: 21.28 Buy
200-day SMA: 16.61 Buy
8-day EMA: 38.79 Buy
20-day EMA: 33.47 Buy
50-day EMA: 25.09 Buy
200-day EMA: 18.34 Buy

Nuveen Municipal Credit Income Fund Earnings Growth & NZF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Nuveen Municipal Credit Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):